Aesthetic practices are unusually well placed to add menopause services, and also unusually exposed to getting the positioning wrong. Both facts come from the same source: you already see this patient, and you already sell her something. This article sets out what carries across from aesthetic practice, what genuinely has to change, and where the risks sit.
In Summary:
| Your existing patient base and your prospective menopause patients are largely the same people. |
| What transfers: the patient relationship, consultation culture, cash-pay experience and follow-up habits. |
| What has to change: appointment length, intake, documentation, referral pathways and how outcomes are measured. |
| The main risk is positioning menopause care as an aesthetic add-on rather than as clinical care. |
Why the overlap is so close
The core aesthetic demographic and the menopause transition occupy the same years. A patient in her late forties booking a consultation is statistically likely to be somewhere in the transition, and quite likely to be experiencing symptoms she has not connected to it.
Several presentations arrive in aesthetic clinics first. Skin dryness and itching, adult acne, thinning hair, changes in facial fat distribution and volume, and abdominal changes are all commonly raised in a cosmetic consultation. Each has a menopausal component that is rarely named in that room.
You also have something most primary care does not: time with the patient, an established relationship, and a consultation culture where discussing how she feels about her body is already normal.
What transfers directly
More than clinic owners usually expect.
- The consultation model. Longer appointments, unhurried discussion and treatment planning are already how you work.
- Cash-pay operations. Transparent pricing, package structures and payment handling are familiar territory.
- Follow-up as a norm. Aesthetic practice already assumes review and adjustment rather than a single visit.
- Patient trust and retention. You are frequently the clinician a patient sees most often and speaks to most candidly.
- Documentation and consent discipline, where the practice already runs it properly.
.
What has to change
The clinical framework is the substantive addition, and it cannot be shortcut. Recognizing the pattern, excluding the conditions that mimic it, and understanding treatment options across the transition are learned skills.
Intake has to change. A menopause service needs menstrual and reproductive history, a symptom review across body systems, screening status, and questions about vaginal, sexual and urinary symptoms that patients will not volunteer. Aesthetic intake forms do not ask any of this.
Appointment structure has to change. An initial menopause assessment does not fit a treatment slot, and the three-month review that determines whether treatment is working is a different kind of appointment from a top-up.
Referral pathways have to exist. You need a defined route for abnormal bleeding, complex history, suspected primary ovarian insufficiency and anything outside your scope, and it needs to be established before you launch rather than located mid-appointment.
Outcome measurement has to change. Aesthetic outcomes are largely visible. Menopause outcomes are reported, which means recording a symptom assessment at baseline and at review.
Where the positioning risk lies
The temptation is to market menopause as another item on a treatment menu, alongside injectables and skin. That framing undercuts the clinical credibility the service depends on, and patients read it quickly.
It also risks the wrong sequence. If a patient with vaginal dryness and painful sex is offered a device before local vaginal estrogen has been discussed, the evidence hierarchy has been inverted for commercial reasons. That is the specific criticism aimed at this sector, and it is sometimes deserved.
The defensible position is that the practice offers clinical care for the menopause transition, delivered by a clinician who has trained in it, and that aesthetic services remain separate services. Patients can and do want both. They should not be sold as one thing.
Practical sequencing for a launch
Train the clinician first. Everything else, protocols, intake, marketing, pricing, follows from clinical competence rather than preceding it.
Then write the scope and the protocols, update intake and documentation, brief the whole team including reception, and establish referral relationships. Only then market the service, and market it as clinical care.
Practices that reverse this order tend to generate demand they are not yet structured to meet, which is the worst possible first impression in a field where patients have usually already been let down once.
What support looks like
EncorVita works with clinics on precisely this transition, combining accredited clinician education with implementation support covering staff training, service structure, pricing, and laboratory and pharmacy arrangements. Clinic-level engagement is arranged through a discovery conversation rather than a standard purchase, so the starting point is a conversation about your practice.
Individual clinicians who want the education first can review the programs at academy.encorvita.com.
Many already raise menopausal symptoms in cosmetic consultations without recognizing them as such. Demand is generally present before the service is announced.
Generally not. The substantive requirements are clinician education, protocols, intake and documentation changes, and referral pathways.
Scope of practice governs this and varies by state and credential. Assessment and prescribing sit with appropriately licensed clinicians, while the wider team supports intake, education and follow-up.
Pricing models vary by practice and state. What matters clinically is that follow-up is integral to the pathway rather than an optional extra purchase.
They can be offered by the same practice but are best presented as distinct services. Framing clinical care as a menu add-on undermines credibility with exactly the patients you want.
It depends on the practice, but the sequence matters more than the speed: clinician training, then protocols and documentation, then team briefing and referral pathways, then marketing.
